Similar articles

• The use of timolol/bendrofluazide (Prestim) in the treatment of hypertensive patients failing to respond to other antihypertensives.

  Ellis R, Wood SJ. Ellis R, et al. J Int Med Res. 1983;11(6):359-63. doi: 10.1177/030006058301100607. J Int Med Res. 1983. PMID: 6140195
• Timolol and bendrofluazide in the management of hypertension in general practice.

  Wheatley D. Wheatley D. Eur J Clin Pharmacol. 1978 Dec 18;14(5):319-24. doi: 10.1007/BF00611900. Eur J Clin Pharmacol. 1978. PMID: 365544 Clinical Trial.
• A multi-centre, general practice assessment of a timolol/bendrofluazide combination ('Prestim') in the treatment of mild to moderate hypertension.

  Head AC. Head AC. Pharmatherapeutica. 1984;3(10):650-6. Pharmatherapeutica. 1984. PMID: 6463065
• A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.

  Marsh BT, Atkins MJ, Talbot DJ, Fairey IT. Marsh BT, et al. J Int Med Res. 1987 Mar-Apr;15(2):106-14. doi: 10.1177/030006058701500208. J Int Med Res. 1987. PMID: 3582721
• A hospital out-patient study of timolol/bendrofluazide combination ('Prestim') in essential hypertension.

  Kubik MM. Kubik MM. Curr Med Res Opin. 1980;7(1):47-54. doi: 10.1185/03007998009116515. Curr Med Res Opin. 1980. PMID: 7428413